Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaxolone Extension for Partial-Onset Seizures
NCT01002820Phase 2Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- Oct 2009
- Primary completion
- Oct 2010
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of ganaxolone in complex partial epilepsy, sponsored by Marinus Pharmaceuticals. Started Oct 2009; status: completed.
02
Drugs
ganaxolone
03
Conditions
complex partial epilepsy
Beyond the preview
Go deeper on NCT01002820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002820.